SCHEMBL18201306

SCHEMBL18201306

c1ccc2c(c1)ccc1c(-c3cnc(-c4ccnc5ccccc45)cn3)nc3ccccc3c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
TGFBR1 P36897 9/20 0.39
CYP3A4 P08684 1/20 0.39
MAPK14 Q16539 6/20 0.39
IDO1 P14902 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GRM4 Q14833 2/20 0.38
HTR2B P41595 1/20 0.38
MTNR1A P48039 1/20 0.38
KCNH2 Q12809 1/20 0.38
ATR Q13535 1/20 0.37
TOP2A P11388 1/20 0.37
TGFBR2 P37173 1/20 0.37
ABL2 P42684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18201311 0.93 ATR (0.45) CYP1A2CYP3A4IDO1NPC1ALDH1A1
SCHEMBL18200819 0.88 MEN1 (0.42) CYP1A2TGFBR1KDM4ENPC1ALDH1A1
SCHEMBL18201274 0.87 TGFBR1 (0.44) CYP1A2TGFBR1CYP3A4MAPK14IDO1
SCHEMBL18200828 0.86 CA12 (0.47) CYP1A2TGFBR1CYP3A4MAPK14IDO1
SCHEMBL18201292 0.86 CYP1A2 (0.42) CYP1A2TGFBR1CYP3A4MAPK14IDO1
SCHEMBL18201312 0.85 KDM4E (0.40) CYP1A2CYP3A4KDM4ENPC1ALDH1A1
SCHEMBL18201077 0.82 ACVR1 (0.42) CYP1A2TGFBR1CYP3A4MAPK14IDO1
SCHEMBL18200807 0.82 NPC1 (0.42) IDO1KDM4ENPC1ALDH1A1HPGD
SCHEMBL18201324 0.82 CYP1A2 (0.45) CYP1A2TGFBR1CYP3A4MAPK14IDO1
SCHEMBL18201166 0.82 CYP1A2 (0.51) CYP1A2TGFBR1CYP3A4MAPK14IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 CYP1A2 134/4885TGFBR1 3161/4885CYP3A4 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.